○Yuki Uchihara¹, Tiara Bunga Mayang Permata², Hiro Sato³, Reika Kawabata- Iwakawa¹, Sayako Katada⁴, Wenchao Gu¹, Sangeeta Kakoti¹, Motohiro Yamauchi⁵, Reona Kato⁶, Soehartati Gondhowiardjo², Naoki Hosen⁷, Takaaki Yasuhara⁶, Atsushi Shibata¹ (1. GIAR, Gunma Univ., 2. Fac. Med., Indonesia Univ., 3. Grad. Sch. Med., Gunma Univ., 4. Grad. Sch. Med., Kyushu Univ., 5. Cen. Inst. Rad. Sci., Kyushu Univ, 6. Grad. Sch. Med., Univ. of Tokyo, 7. Grad. Sch. Med., Osaka Univ.)

○Wakana Suzuki¹, Midori Suzuki¹, Yusuke Hirata¹, Takuya Noguchi¹, Atsushi Matsuzawa¹ (1. Lab of Health Chem., Grad. Sch. of Pharmaceut. Sci., Tohoku Univ.)

○Yu Kato¹, Yukari Fukazawa¹, Shingo Kondo¹, Yoshikazu Sugimoto¹ (1. Div. Chemother., Facul. Pharm., Keio Univ.)

○Takumi Iwasawa^1,2, Noriaki Iwao^2,3, Kazunori Kato^1,4, Chikao Morimoto⁵ (1. Dept. Biomed. Eng., Grad. Sch. Sci. Eng., Toyo Univ.,, 2. Shizuoka Med. Rese. Center for Disaster., Juntendo Univ., 3. Dept. Hematology, Shizuoka Hosp., Juntendo Univ., 4. Atopy Rese. Center, Juntendo Univ., 5. Dept. of Thera. Develop. & Innova. for Immune Disor. & Cancers, Juntendo Univ.)

○Itsuki Yamaguchi¹, Hironori Katoh¹ (1. Laboratory of Molecular Neurobiology, Graduate School of Biostudies, Kyoto University)

○Taiki Furutani¹, Yuto Takemoto¹, Kenjiro Tanaka¹, Ryuji Kato^1,2 (1. Grad. Sch. Pharm. Sci., Nagoya Univ., 2. Inst. Nano-Life-Systems, Nagoya Univ.)

○Takumi Hoshino¹, Masashi Uchida^1,2, Shiho Anno³, Katsuhiko Kida³, Daisuke Hatanaka³, Masaki Kobayashi³, Takaaki Suzuki^1,2, Itsuko Ishii^1,2 (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Division of pharmacy, Chiba Univ. Hosp., 3. Nissan Chemical Corp.)